Bone Biologics Corporation (BBLG)
USD 0.71
(-17.43%)
USD 0.71
(-17.43%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.73 Million USD | -56.0% |
| 2022 | 8.49 Million USD | 27.26% |
| 2021 | 6.67 Million USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 30.82 Thousand USD | -97.04% |
| 2018 | 1.04 Million USD | 30.8% |
| 2017 | 795.65 Thousand USD | -18.23% |
| 2016 | 973.08 Thousand USD | -53.22% |
| 2015 | 2.08 Million USD | -45.56% |
| 2014 | 3.82 Million USD | 4277.06% |
| 2013 | 87.3 Thousand USD | 3683655.27% |
| 2012 | 2.37 USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 100.0% |
| 2009 | -39.77 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.83 Million USD | 2.72% |
| 2024 Q2 | 3.19 Million USD | -16.83% |
| 2023 Q3 | 4.97 Million USD | -34.72% |
| 2023 FY | 3.73 Million USD | -56.0% |
| 2023 Q1 | 6.78 Million USD | -20.15% |
| 2023 Q2 | 7.62 Million USD | 12.37% |
| 2023 Q4 | 3.73 Million USD | -24.89% |
| 2022 Q3 | 5.2 Million USD | -8.09% |
| 2022 Q4 | 8.49 Million USD | 63.34% |
| 2022 Q1 | 6.09 Million USD | -8.71% |
| 2022 FY | 8.49 Million USD | 27.26% |
| 2022 Q2 | 5.65 Million USD | -7.14% |
| 2021 Q4 | 6.67 Million USD | 12640.95% |
| 2021 FY | 6.67 Million USD | 0.0% |
| 2021 Q2 | 4438.00 USD | -93.76% |
| 2021 Q3 | 52.39 Thousand USD | 1080.55% |
| 2021 Q1 | 71.16 Thousand USD | 116.67% |
| 2020 Q1 | 6964.00 USD | -77.41% |
| 2020 FY | - USD | -100.0% |
| 2020 Q2 | 1433.00 USD | -79.42% |
| 2020 Q3 | 2461.00 USD | 71.74% |
| 2020 Q4 | -426.93 Thousand USD | -17447.95% |
| 2019 Q1 | 814.08 Thousand USD | -21.78% |
| 2019 FY | 30.82 Thousand USD | -97.04% |
| 2019 Q3 | 249.34 Thousand USD | -6.4% |
| 2019 Q4 | 30.82 Thousand USD | -87.64% |
| 2019 Q2 | 266.39 Thousand USD | -67.28% |
| 2018 Q3 | 2.35 Million USD | 522.19% |
| 2018 FY | 1.04 Million USD | 30.8% |
| 2018 Q1 | 470.49 Thousand USD | -40.87% |
| 2018 Q2 | 377.74 Thousand USD | -19.71% |
| 2018 Q4 | 1.04 Million USD | -55.72% |
| 2017 Q3 | 1.94 Million USD | 70.17% |
| 2017 FY | 795.65 Thousand USD | -18.23% |
| 2017 Q4 | 795.65 Thousand USD | -59.0% |
| 2017 Q2 | 1.14 Million USD | -42.05% |
| 2017 Q1 | 1.96 Million USD | 102.23% |
| 2016 FY | 973.08 Thousand USD | -53.22% |
| 2016 Q2 | 2.63 Million USD | -43.0% |
| 2016 Q1 | 4.62 Million USD | 122.19% |
| 2016 Q4 | 973.08 Thousand USD | -9.25% |
| 2016 Q3 | 1.07 Million USD | -59.3% |
| 2015 FY | 2.08 Million USD | -45.56% |
| 2015 Q1 | 3.21 Million USD | -15.84% |
| 2015 Q4 | 2.08 Million USD | -36.99% |
| 2015 Q3 | 3.3 Million USD | -25.19% |
| 2015 Q2 | 4.41 Million USD | 37.23% |
| 2014 Q3 | 420.13 Thousand USD | 233.23% |
| 2014 FY | 3.82 Million USD | 4277.06% |
| 2014 Q4 | 3.82 Million USD | 809.57% |
| 2014 Q2 | 126.07 Thousand USD | 217277.59% |
| 2014 Q1 | 58.00 USD | -99.93% |
| 2013 Q3 | - USD | -100.0% |
| 2013 Q4 | 87.3 Thousand USD | 0.0% |
| 2013 FY | 87.3 Thousand USD | 3683655.27% |
| 2013 Q1 | 440.00 USD | -6.38% |
| 2013 Q2 | 410.00 USD | -6.82% |
| 2012 Q4 | 470.00 USD | 107.76% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | -6057.00 USD | 0.0% |
| 2012 FY | 2.37 USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | -39.77 Thousand USD | 0.0% |
| 2009 Q4 | - USD | 100.0% |
| 2009 Q3 | -39.77 Thousand USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 Q3 | -24.32 Thousand USD | -12.45% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | 849.00 USD | 103.49% |
| 2008 Q1 | -27.16 Thousand USD | -136.06% |
| 2008 Q2 | -21.63 Thousand USD | 20.36% |
| 2007 Q4 | -11.5 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 88.083% |
| BrainsWay Ltd. | 62.97 Million USD | 94.064% |
| Cerus Corporation | 197.74 Million USD | 98.11% |
| Envoy Medical, Inc. | 7.64 Million USD | 51.076% |
| electroCore, Inc. | 16.38 Million USD | 77.191% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 51.407% |
| IceCure Medical Ltd | 16.41 Million USD | 77.223% |
| Inogen, Inc. | 326.19 Million USD | 98.854% |
| OrthoPediatrics Corp. | 449.58 Million USD | 99.169% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 86.293% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 77.455% |
| MaxCyte, Inc. | 268.27 Million USD | 98.607% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 53.839% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2.914% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.596% |
| PAVmed Inc | 33.11 Million USD | 88.714% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 97.394% |
| RxSight, Inc. | 182.55 Million USD | 97.952% |
| Sight Sciences, Inc. | 166.65 Million USD | 97.757% |
| SI-BONE, Inc. | 230.42 Million USD | 98.378% |
| TELA Bio, Inc. | 78.04 Million USD | 95.211% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 98.516% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 65.165% |
| Acutus Medical, Inc. | 53.96 Million USD | 93.073% |
| Talis Biomedical Corporation | 98.34 Million USD | 96.199% |
| Spectral AI, Inc. | 10.69 Million USD | 65.041% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 98.291% |
| CVRx, Inc. | 115.22 Million USD | 96.756% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 93.628% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -19.983% |
| Bioventus Inc. | 810.91 Million USD | 99.539% |
| Venus Concept Inc. | 93.65 Million USD | 96.009% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 85.47% |
| LivaNova PLC | 2.42 Billion USD | 99.846% |
| 908 Devices Inc. | 202.98 Million USD | 98.159% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.536% |
| Nemaura Medical Inc. | 14.56 Million USD | 74.334% |
| NeuroPace, Inc. | 107.65 Million USD | 96.528% |
| LENSAR, Inc. | 69.58 Million USD | 94.628% |
| Apyx Medical Corporation | 79.24 Million USD | 95.283% |
| Cutera, Inc. | 346.29 Million USD | 98.921% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 91.104% |
| BioSig Technologies, Inc. | 1.79 Million USD | -107.884% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 98.619% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 91.238% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.901% |
| Axonics, Inc. | 719.92 Million USD | 99.481% |
| Outset Medical, Inc. | 313.8 Million USD | 98.809% |
| IRIDEX Corporation | 34.43 Million USD | 89.146% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 99.076% |
| IRadimed Corporation | 92.15 Million USD | 95.944% |
| Tivic Health Systems, Inc. | 5.25 Million USD | 28.859% |
| INVO Bioscience, Inc. | 20.88 Million USD | 82.106% |
| Telesis Bio, Inc. | 70.41 Million USD | 94.692% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 97.574% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.701% |
| Quipt Home Medical Corp. | 247.4 Million USD | 98.489% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 59.852% |
| Pulmonx Corporation | 178.95 Million USD | 97.911% |
| Dynatronics Corporation | 25.94 Million USD | 85.591% |
| Modular Medical, Inc. | 13.8 Million USD | 72.928% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 65.156% |
| Semler Scientific, Inc. | 78.06 Million USD | 95.212% |
| InMode Ltd. | 863.28 Million USD | 99.567% |
| Bruker Corporation | 4.24 Billion USD | 99.912% |
| Cytosorbents Corporation | 53.26 Million USD | 92.982% |
| DexCom, Inc. | 6.26 Billion USD | 99.94% |
| Align Technology, Inc. | 6.08 Billion USD | 99.939% |
| Viveve Medical, Inc. | 25.91 Million USD | 85.576% |
| ZimVie Inc. | 1.2 Billion USD | 99.69% |
| Movano Inc. | 9.42 Million USD | 60.325% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 99.249% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2.914% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 93.628% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.608% |
| Profound Medical Corp. | 43.68 Million USD | 91.444% |
| Insulet Corporation | 2.58 Billion USD | 99.856% |
| enVVeno Medical Corporation | 48.63 Million USD | 92.315% |
| Surmodics, Inc. | 185.73 Million USD | 97.988% |
| iCAD, Inc. | 41.41 Million USD | 90.976% |
| Nuwellis, Inc. | 9.77 Million USD | 61.742% |
| Biotricity, Inc. | 5.94 Million USD | 37.102% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 99.137% |
| Aethlon Medical, Inc. | 8.24 Million USD | 54.672% |
| InspireMD, Inc. | 47.64 Million USD | 92.155% |
| PAVmed Inc. | 33.11 Million USD | 88.714% |
| BIOLASE, Inc. | 35.1 Million USD | 89.351% |
| Beyond Air, Inc. | 56.96 Million USD | 93.438% |
| FONAR Corporation | 214.24 Million USD | 98.255% |
| AxoGen, Inc. | 196.82 Million USD | 98.101% |
| Vivani Medical, Inc. | 45.79 Million USD | 91.838% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 98.672% |
| Inari Medical, Inc. | 674.23 Million USD | 99.446% |
| UFP Technologies, Inc. | 404.13 Million USD | 99.075% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 84.026% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 60.668% |
| Tenon Medical, Inc. | 6.34 Million USD | 41.091% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 60.266% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 96.394% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.919% |
| Sintx Technologies, Inc. | 15.36 Million USD | 75.674% |
| NanoVibronix, Inc. | 6.67 Million USD | 43.995% |
| Quanterix Corporation | 425.01 Million USD | 99.121% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 59.852% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 93.043% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.786% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.471% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 94.085% |
| NeuroMetrix, Inc. | 21.42 Million USD | 82.554% |
| Hyperfine, Inc. | 94.19 Million USD | 96.032% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 98.609% |
| Biomerica, Inc. | 9.25 Million USD | 59.609% |
| AVITA Medical, Inc. | 144.33 Million USD | 97.41% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | 23.226% |
| Silk Road Medical, Inc | 265.3 Million USD | 98.591% |